Anthelmintic Drugs Market Report 2026
Download Free Sample Buy Now
Anthelmintic Drugs Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Anthelmintic Drugs Market Report 2026

Global Outlook – By Drug Class (Benzimidazoles, Macrocyclic lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, Other Drug Classes), By Route Of Administration (Oral, Injectable), By Infection Type (Nematode Infections, Cestode Infections, Trematode Infections, Mixed Infections), By Distribution Channel (Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics And Supply Stores), By Application (Human Anthelmintics, Veterinary Anthelmintics) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Anthelmintic Drugs Market Overview

• Anthelmintic Drugs market size has reached to $3.34 billion in 2025

• Expected to grow to $4.32 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%

• Growth Driver: Increasing Parasitic Infections To Drive Market Growth For Anthelmintic Drugs

• Market Trend: Advancing Parasite Control With Targeted Deworming

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Anthelmintic Drugs Market?

Anthelmintic drugs are medications used to treat infections caused by parasitic worms, or helminths. These drugs work by either killing the worms directly or disrupting their ability to reproduce. They are commonly prescribed for conditions such as roundworm, tapeworm, and hookworm infections.

The main drug classes of anthelmintic drugs are benzimidazoles, macrocyclic lactones, pyrazinoisoquinolones, tetrahydropyrimidines, and others. Benzimidazoles are a class of organic compounds characterized by a benzene ring fused with an imidazole ring. They are used in various applications, including as pharmaceutical agents for treating parasitic infections and as key components in some synthetic materials. They are administered via oral and injectable routes to treat various infections, including nematode, cestode, trematode, and mixed infections. They are distributed through various channels such as hospitals and clinics, retail pharmacies, online pharmacies, and veterinary clinics and supply stores, and are applied in human and veterinary anthelmintics.

Anthelmintic Drugs Market Global Report 2026 Market Report bar graph

What Is The Anthelmintic Drugs Market Size and Share 2026?

The anthelmintic drugs market size has grown strongly in recent years. It will grow from $3.34 billion in 2025 to $3.53 billion in 2026 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to high prevalence of parasitic infections, limited access to advanced anthelmintic drugs, reliance on traditional drug classes, growing awareness of helminth infections, expanding hospital and clinic infrastructure.

What Is The Anthelmintic Drugs Market Growth Forecast?

The anthelmintic drugs market size is expected to see strong growth in the next few years. It will grow to $4.32 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to development of novel anthelmintic compounds, increasing adoption of combination therapies, rising veterinary and livestock applications, expansion of online and retail pharmacy channels, government initiatives for parasite control programs. Major trends in the forecast period include rising prevalence of helminth infections in humans and animals, growing adoption of oral anthelmintics and injectable formulations, increasing demand for veterinary anthelmintics in livestock management, expansion of retail and online pharmacy channels for anthelmintic drugs, focus on combination therapies and broad-spectrum anthelmintics.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Anthelmintic Drugs Market Segmentation

1) By Drug Class: Benzimidazoles, Macrocyclic lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, Other Drug Classes

2) By Route Of Administration: Oral, Injectable

3) By Infection Type: Nematode Infections, Cestode Infections, Trematode Infections, Mixed Infections

4) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics And Supply Stores

5) By Application: Human Anthelmintics, Veterinary Anthelmintics

Subsegments:

1) By Benzimidazoles: Albendazole, Mebendazole, Fenbendazole, Oxfendazole, Thiabendazole

2) By Macrocyclic Lactones: Ivermectin, Moxidectin, Doramectin, Eprinomectin, Milbemycin Oxime

3) By Pyrazinoisoquinolones: Praziquantel, Cysticide

4) By Tetrahydropyrimidines: Pyrantel Pamoate, Pyrantel Tartrate

5) By Other Drug Classes: Imidazothiazoles, Aminoacetonitrile Derivatives, Spiroindoles, Arsenicals

What Is The Driver Of The Anthelmintic Drugs Market?

The high prevalence of parasitic infections is expected to propel the growth of the anthelmintic drugs market going forward. Parasitic infections are diseases caused by organisms that live on or inside another host, such as parasites such as protozoa, worms, or ectoparasites. Parasitic infections are fueled by poor sanitation, contaminated food or water, close contact with infected individuals or animals, inadequate hygiene, and a lack of access to clean resources. Anthelmintic drugs are used to treat infections caused by parasitic worms, effectively targeting and eliminating these parasites from the host's body. These medications work by disrupting the parasites' physiological functions, leading to their expulsion or death. For instance, in September 2025, according to the data published by the Centers for Disease Control and Prevention, a US-based national public health agency, as of September 16, 2025, the CDC had received reports of 990 cases of cyclosporiasis acquired in the United States. Therefore, the high prevalence of parasitic infections is driving the growth of the anthelmintic drugs industry.

Key Players In The Global Anthelmintic Drugs Market

Major companies operating in the anthelmintic drugs market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Galderma S.A., Cipla Inc., Ferring Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Mankind Pharma Ltd., Reese Pharmaceutical Company

Global Anthelmintic Drugs Market Trends and Insights

Major companies operating in the anthelmintic drugs market are focusing on developing innovative solutions, such as targeted, evidence-based deworming programs, to improve parasite control, reduce drug resistance, and promote sustainable use of anthelmintics compared with traditional blanket deworming approaches that often rely on frequent, untargeted treatments. Targeted deworming programs leverage diagnostic testing, parasite load assessment, and strategic dosing schedules to optimize treatment efficacy while minimizing environmental and resistance risks. For instance, in April 2025, Zoetis Inc., a US-based animal health company, launched the “Buy Less Dewormer” campaign for equine populations, promoting evidence-based parasite management. The program combines educational resources with guidance on fecal egg count monitoring and strategic anthelmintic selection; it functions by encouraging horse owners and veterinarians to administer treatments only when necessary, based on parasite burden and risk assessment; unique features include integrated educational materials, risk-based treatment recommendations, and support for sustainable anthelmintic stewardship; applications span equine herd health management, prevention of parasite resistance, and optimized deworming schedules; benefits include reduced anthelmintic overuse, improved parasite control outcomes, lower costs for owners, and promotion of long-term drug efficacy.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Anthelmintic Drugs Market?

In July 2023, Bayer AG, a Germany-based pharmaceutical and biotechnology company, partnered with the Swiss Tropical and Public Health Institute (Swiss TPH) to develop anthelmintic drug compounds for treating parasitic infections. The collaboration aims to evaluate the safety and efficacy of emodepside, a compound initially developed for veterinary use, for human treatment of soil-transmitted helminths, provide a new treatment option and advance global health efforts by addressing a major public health challenge in developing regions. The Swiss Tropical and Public Health Institute (Swiss TPH) is a Switzerland-based research institute that focuses on global health and tropical diseases.

Regional Insights

North America was the largest region in the anthelmintic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Anthelmintic Drugs Market?

The anthelmintic drugs market consists of sales of albendazole, mebendazole, praziquantel, levamisole, piperazine, and ivermectin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anthelmintic Drugs Market Report 2026?

The anthelmintic drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anthelmintic drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Anthelmintic Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $3.53 billion
Revenue Forecast In 2035 $4.32 billion
Growth Rate CAGR of 5.5% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Drug Class, Route Of Administration, Infection Type, Distribution Channel, Application
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun P
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Anthelmintic Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Anthelmintic Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Anthelmintic Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Anthelmintic Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Prevalence Of Helminth Infections In Humans And Animals

4.2.2 Growing Adoption Of Oral Anthelmintics And Injectable Formulations

4.2.3 Increasing Demand For Veterinary Anthelmintics In Livestock Management

4.2.4 Expansion Of Retail And Online Pharmacy Channels For Anthelmintic Drugs

4.2.5 Focus On Combination Therapies And Broad-Spectrum Anthelmintics

5. Anthelmintic Drugs Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Retail Pharmacies

5.3 Online Pharmacies

5.4 Veterinary Clinics And Supply Stores

5.5 Livestock Farms

6. Anthelmintic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Anthelmintic Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Anthelmintic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Anthelmintic Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Anthelmintic Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Anthelmintic Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Anthelmintic Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Anthelmintic Drugs Market Segmentation

9.1. Global Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Benzimidazoles, Macrocyclic Lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, Other Drug Classes

9.2. Global Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Injectable

9.3. Global Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nematode Infections, Cestode Infections, Trematode Infections, Mixed Infections

9.4. Global Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics And Supply Stores

9.5. Global Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Human Anthelmintics, Veterinary Anthelmintics

9.6. Global Anthelmintic Drugs Market, Sub-Segmentation Of Benzimidazoles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Albendazole, Mebendazole, Fenbendazole, Oxfendazole, Thiabendazole

9.7. Global Anthelmintic Drugs Market, Sub-Segmentation Of Macrocyclic Lactones, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ivermectin, Moxidectin, Doramectin, Eprinomectin, Milbemycin Oxime

9.8. Global Anthelmintic Drugs Market, Sub-Segmentation Of Pyrazinoisoquinolones, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Praziquantel, Cysticide

9.9. Global Anthelmintic Drugs Market, Sub-Segmentation Of Tetrahydropyrimidines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pyrantel Pamoate, Pyrantel Tartrate

9.10. Global Anthelmintic Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Imidazothiazoles, Aminoacetonitrile Derivatives, Spiroindoles, Arsenicals

10. Anthelmintic Drugs Market Regional And Country Analysis

10.1. Global Anthelmintic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Anthelmintic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Anthelmintic Drugs Market

11.1. Asia-Pacific Anthelmintic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Anthelmintic Drugs Market

12.1. China Anthelmintic Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Anthelmintic Drugs Market

13.1. India Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Anthelmintic Drugs Market

14.1. Japan Anthelmintic Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Anthelmintic Drugs Market

15.1. Australia Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Anthelmintic Drugs Market

16.1. Indonesia Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Anthelmintic Drugs Market

17.1. South Korea Anthelmintic Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Anthelmintic Drugs Market

18.1. Taiwan Anthelmintic Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Anthelmintic Drugs Market

19.1. South East Asia Anthelmintic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Anthelmintic Drugs Market

20.1. Western Europe Anthelmintic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Anthelmintic Drugs Market

21.1. UK Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Anthelmintic Drugs Market

22.1. Germany Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Anthelmintic Drugs Market

23.1. France Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Anthelmintic Drugs Market

24.1. Italy Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Anthelmintic Drugs Market

25.1. Spain Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Anthelmintic Drugs Market

26.1. Eastern Europe Anthelmintic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Anthelmintic Drugs Market

27.1. Russia Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Anthelmintic Drugs Market

28.1. North America Anthelmintic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Anthelmintic Drugs Market

29.1. USA Anthelmintic Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Anthelmintic Drugs Market

30.1. Canada Anthelmintic Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Anthelmintic Drugs Market

31.1. South America Anthelmintic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Anthelmintic Drugs Market

32.1. Brazil Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Anthelmintic Drugs Market

33.1. Middle East Anthelmintic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Anthelmintic Drugs Market

34.1. Africa Anthelmintic Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Anthelmintic Drugs Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Anthelmintic Drugs Market Regulatory and Investment Landscape

36. Anthelmintic Drugs Market Competitive Landscape And Company Profiles

36.1. Anthelmintic Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Anthelmintic Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Anthelmintic Drugs Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Anthelmintic Drugs Market Other Major And Innovative Companies

Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Galderma S.A., Cipla Inc., Ferring Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Mankind Pharma Ltd.

38. Global Anthelmintic Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Anthelmintic Drugs Market

40. Anthelmintic Drugs Market High Potential Countries, Segments and Strategies

40.1 Anthelmintic Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Anthelmintic Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Anthelmintic Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Anthelmintic Drugs Market, Overview Of Key Products - Product Examples
  • Table 2: Global Anthelmintic Drugs Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Anthelmintic Drugs Market, Supply Chain Analysis
  • Table 4: Global Anthelmintic Drugs Market, Major Raw Material Providers
  • Table 5: Global Anthelmintic Drugs Market, Major Resource Providers
  • Table 6: Global Anthelmintic Drugs Market, Major Manufacturers (Suppliers)
  • Table 7: Global Anthelmintic Drugs Market, Major Distributors And Channel Partners
  • Table 8: Global Anthelmintic Drugs Market, Key Technologies & Future Trends
  • Table 9: Global Anthelmintic Drugs Market, Major Trends
  • Table 10: Global Anthelmintic Drugs Market, Major End Users
  • Table 11: Global Anthelmintic Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Anthelmintic Drugs Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Anthelmintic Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Anthelmintic Drugs Market - TAM, US$ Billion, 2025
  • Table 15: Global Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Anthelmintic Drugs Market, Sub-Segmentation Of Benzimidazoles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Anthelmintic Drugs Market, Sub-Segmentation Of Macrocyclic Lactones, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Anthelmintic Drugs Market, Sub-Segmentation Of Pyrazinoisoquinolones, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Anthelmintic Drugs Market, Sub-Segmentation Of Tetrahydropyrimidines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Anthelmintic Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Anthelmintic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Anthelmintic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Global Anthelmintic Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 100: Global Anthelmintic Drugs Market - Company Scoring Matrix
  • Table 101: Pfizer Inc. Financial Performance
  • Table 102: Johnson & Johnson Financial Performance
  • Table 103: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 104: Merck & Co. Inc. Financial Performance
  • Table 105: Bayer AG Financial Performance
  • Table 106: Global Anthelmintic Drugs Market, Competitive Benchmarking (In USD Billions)
  • Table 107: Global Anthelmintic Drugs Market, Competitive Dashboard
  • Table 108: Global Anthelmintic Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 109: Global, Anthelmintic Drugs Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Table 110: Global, Anthelmintic Drugs Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 111: Global, Anthelmintic Drugs Market Size Gain ($ Billion), Segmentation By Infection Type, 2025 – 2030

List Of Figures

    Figure 1: Global Anthelmintic Drugs Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Anthelmintic Drugs Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Anthelmintic Drugs Market, Supply Chain Analysis
  • Figure 4: Global Anthelmintic Drugs Market, Major Raw Material Providers
  • Figure 5: Global Anthelmintic Drugs Market, Major Resource Providers
  • Figure 6: Global Anthelmintic Drugs Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Anthelmintic Drugs Market, Major Distributors And Channel Partners
  • Figure 8: Global Anthelmintic Drugs Market, Key Technologies & Future Trends
  • Figure 9: Global Anthelmintic Drugs Market, Major Trends
  • Figure 10: Global Anthelmintic Drugs Market, Major End Users
  • Figure 11: Global Anthelmintic Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Anthelmintic Drugs Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Anthelmintic Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Anthelmintic Drugs Market - TAM, US$ Billion, 2025
  • Figure 15: Global Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Anthelmintic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Anthelmintic Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Anthelmintic Drugs Market, Sub-Segmentation Of Benzimidazoles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Anthelmintic Drugs Market, Sub-Segmentation Of Macrocyclic Lactones, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Anthelmintic Drugs Market, Sub-Segmentation Of Pyrazinoisoquinolones, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Anthelmintic Drugs Market, Sub-Segmentation Of Tetrahydropyrimidines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Anthelmintic Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Anthelmintic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Anthelmintic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Anthelmintic Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Anthelmintic Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Anthelmintic Drugs Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Global Anthelmintic Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 100: Global Anthelmintic Drugs Market - Company Scoring Matrix
  • Figure 101: Pfizer Inc. Financial Performance
  • Figure 102: Johnson & Johnson Financial Performance
  • Figure 103: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 104: Merck & Co. Inc. Financial Performance
  • Figure 105: Bayer AG Financial Performance
  • Figure 106: Global Anthelmintic Drugs Market, Competitive Benchmarking (In USD Billions)
  • Figure 107: Global Anthelmintic Drugs Market, Competitive Dashboard
  • Figure 108: Global Anthelmintic Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 109: Global, Anthelmintic Drugs Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Figure 110: Global, Anthelmintic Drugs Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 111: Global, Anthelmintic Drugs Market Size Gain ($ Billion), Segmentation By Infection Type, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Kidney Cancer Drugs Market Report 2026 - Global Outlook – By Cancer Type (Renal Cell Carcinoma (RCC), Transitional Cell Carcinoma (TCC) Or Urothelial Cell Carcinoma (UCC)), By Product (Nexavar (Sorafenib), Sutent (Suniti...

Prostate Cancer Drugs Market Report 2026 - Global Outlook – By Type (Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer), By Therapy (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), B...

Ovarian Cancer Drugs Market Report 2026 - Global Outlook – By Tumor Type (Epithelial Ovarian Cancer, Germ Cell Ovarian Cancer, Stromal Cell Ovarian Cancer), By Drug Type (Alkylating Agents, Mitotic Inhibitors, VEGF/VEGFR...

Fertility Drugs Market Report 2026 - Global Outlook – By Type Of Drug (Prescription Fertility Drugs, Over-The-Counter Fertility drugs , By Route of Administration (Oral, Intravenous, Subcutaneous, Intramuscular , By Dist...

Drugs For Benign Prostatic hypertrophy Market Report 2026 - Global Outlook – By Type (Alpha Blocker, 5-alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor, Other Types), By Distribution Channel (Hospital Pharmacies,...

Thyroid Cancer Drugs Market Report 2026 - Global Outlook – By Drug Type (Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib, Other Drug Types),...

Gastric Cancer Drugs Market Report 2026 - Global Outlook – By Type (Imatinib, Trastuzumab, Other Types), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Clinics, Cancer Speciality Centers) – Market...

Insulin Drugs Market Report 2026 - Global Outlook – By Product Type (Basal Or Long-Acting Insulins, Bolus Or Fast-Acting Insulins, Pre-Mixed, Intermediate And Short Acting Insulins), By Source Type (Insulin Analogs, And ...

Frequently Asked Questions

The Anthelmintic Drugs market was valued at $3.34 billion in 2025, increased to $3.53 billion in 2026, and is projected to reach $4.32 billion by 2030.

The global Anthelmintic Drugs market is expected to grow at a CAGR of 5.2% from 2026 to 2035 to reach $4.32 billion by 2035.

Some Key Players in the Anthelmintic Drugs market Include, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Galderma S.A., Cipla Inc., Ferring Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Mankind Pharma Ltd., Reese Pharmaceutical Company .

Major trend in this market includes: Advancing Parasite Control With Targeted Deworming. For further insights on this market. request a sample here

North America was the largest region in the anthelmintic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthelmintic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us